Litcius/Paper detail

Role of immunohistochemistry markers in neoplastic lung lesions

Srikanth Umakanthan, A. V. Chalapathi Rao, Wayne Mohammed

2021Journal of Cancer Research and Therapeutics10 citationsDOIOpen Access PDF

Abstract

OBJECTIVES: The objective of the evaluate was to study and determine the usefulness of immunohistochemistry (IHC) staining in neoplastic lung lesions. MATERIALS AND METHODS: We evaluated seven IHC stains in fifty lung cancers that included adenocarcinoma (AC), squamous cell carcinoma (SCC), small cell carcinoma, and carcinoid tumors. RESULTS: P63 was expressed in all the cases of SCCs and thyroid transcription factor-1 (TTF-1) was expressed in all cases of ACs. CK 5/6 was expressed in 77.77% of SCCs and CK 7 was expressed in 92.59% of ACs. Synaptophysin and chromogranin-A were expressed in 100% of neuroendocrine (NE) carcinomas. CONCLUSION: P63 and TTF-1 are sensitive markers for SCCs and ACs. Synaptophysin and Chromogranin-A are sensitive markers for NE carcinomas.

Topics & Concepts

SynaptophysinChromogranin AImmunohistochemistryPathologyAdenocarcinomaThyroid Transcription Factor 1LungMedicineCarcinomaLung cancerCancerInternal medicineLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentCongenital Diaphragmatic Hernia Studies
Role of immunohistochemistry markers in neoplastic lung lesions | Litcius